Mandatory notice of trade in IDEX – allocation in placement
IDEX ASA issues this notice on behalf of primary insiders in the company.
Reference is made to the notice today about the subscription and allocation in the private placement in IDEX.
Marc O’Polo Norge AS, a company controlled by IDEX’s chairman Morten Opstad was allocated 199,880 shares in the placement. After this transaction, Mr. Opstad and his close associates’ holding will be 6,559,725 shares and 0 (nil) rights to shares in IDEX.
Board member Jon Ola Frankplads was allocated 199,880 shares in the placement. After this transaction, Mr. Frankplads and his close associates’ holding will be 3,912,432 shares and and 0 (nil) rights to shares in IDEX.
Board member Hanne Høvding was allocated 37 480 shares in the placement. After this transaction, Ms. Høvding and her close associates’ holding will be 293,477 shares and 29,657 subscription rights in IDEX.
Board member Joan Frost Urstad was allocated 9,990 shares in the placement. After this transaction, Ms. Urstad and her close associates’ holding will be 304,580 shares and 59,314 subscription rights in IDEX.
Investor relations officer Inge Berge was allocated 66,630 shares in the placement. After this transaction, Mr. Berge and his close associates’ holding will be 66,630 shares and 3,000,000 subscription rights in IDEX.
IDEX also discloses that Lupum AS, a company controlled by IDEX’s adviser and shareholder Kristian Wiermyhr, was allocated 199,880 shares in the placement. After this transaction, Mr. Wiermyhr and his close associates’ holding will be 3,441,485 shares and 3,000,000 subscription rights in IDEX.
Furthermore, IDEX confirms that allocation to the IDEX internal subscribers in the book building was a lower percentage of their subscriptions than the allocation percentage to the external subscribers.
9 November 2012
IDEX ASA
Contacts:
Ralph W. Bernstein, CEO, +47 9305 9303, ralph.bernstein@idexbiometrics.com
Inge Berge, Investor relations contact, +47 9326 8836, inge.berge@idexbiometrics.com
About IDEX ASA
IDEX ASA is a Norwegian public company specializing in fingerprint imaging and recognition technology. IDEX’ vision is to ensure individuals a safe, secure, and user-friendly use of personal ID. IDEX has developed the award-winning SmartFinger Film technology platform including the patented fingerprint imaging principle, sensing scheme and chip design. The SmartFinger technology is available to customers under an intellectual property licensing scheme or as SmartFinger Film sensor assemblies for integration into customers’ products. For more information, please visit www.idexbiometrics.com or contact IDEX at: mailbox@idexbiometrics.com.
